Fig. 4
From: Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
Image panel of patients #1, #2, and #3 displaying representative sections through individual fibrolamellar carcinoma in contrast enhanced imaging techniques including hepatic arterial phase T1 weighted imaging (HAP), portal venous phase T1 weighted imaging (PVP), and hepatobiliary phase T1 weighted imaging (HBP). In patients with history of TACE prior to gadoxetic acid enhanced MRI (#5) areas of non-viable tumor are indicated in the portal venous phase (arrows) and areas of viable tumor are indicated in the hepatic arterial phase (star)